Targeting HDAC6 to reduce the aggressiveness of metastatic breast cancer in immunotherapy

被引：1
|
作者：
Banik, Debarati [1 ]
Hadley, Melissa [1 ]
Palmer, Erica [1 ]
Gallub, Vincent [1 ]
Sotomayor, Eduardo [1 ]
Kozikowski, Alan [2 ]
Villagra, Alejandro [1 ]
机构：
[1] George Washington Univ, Hyattsville, MD USA
[2] Starwise, Madison, WI USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-48
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
48
引用
收藏
页数：2
相关论文
共 50 条
  • [31] HDAC6 inhibition is a novel strategy to selectively impact inflammatory breast cancer cell survival
    Putcha, Preeti
    Yu, Jiyang
    Califano, Andrea
    Silva, Jose
    CANCER RESEARCH, 2014, 74 (19)
  • [32] HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
    Hideshima, Teru
    Mazitschek, Ralph
    Qi, Jun
    Mimura, Naoya
    Tseng, Jen-Chieh
    Kung, Andrew L.
    Bradner, James E.
    Anderson, Kenneth C.
    ONCOTARGET, 2017, 8 (46) : 80109 - 80123
  • [33] HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer
    Cortesi, Michela
    Bravaccini, Sara
    Ravaioli, Sara
    Petracci, Elisabetta
    Angeli, Davide
    Tumedei, Maria Maddalena
    Balzi, William
    Pirini, Francesca
    Zanoni, Michele
    Possanzini, Paola
    Rocca, Andrea
    Palleschi, Michela
    Ulivi, Paola
    Martinelli, Giovanni
    Maltoni, Roberta
    CANCERS, 2024, 16 (22)
  • [34] HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin
    Zuo, Qinqin
    Wu, Wenjing
    Li, Xu
    Zhao, Le
    Chen, Wei
    ONCOLOGY REPORTS, 2012, 27 (03) : 819 - 824
  • [35] HDAC-targeting epigenetic modulators for cancer immunotherapy
    Cheng, Binbin
    Pan, Wei
    Xiao, Yao
    Ding, Zongbao
    Zhou, Yingxing
    Fei, Xiaoting
    Liu, Jin
    Su, Zhenhong
    Peng, Xiaopeng
    Chen, Jianjun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 265
  • [36] Immunotherapy of metastatic breast cancer
    Hartkopf, Andreas Daniel
    ONKOLOGIE, 2024, 30 (06): : 485 - 489
  • [37] Immunotherapy for metastatic breast cancer
    Sugie, Tomoharu
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [38] HDAC6 modulates colon cancer cell migration and invasion
    Li, Hui
    CANCER RESEARCH, 2020, 80 (16)
  • [39] Lack of HDAC1 and HDAC2 promote breast cancer aggressiveness
    Kamarulzaman, N. S.
    Dewadas, H. D.
    Yaacob, N. S.
    Mokhtar, N. F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [40] HDAC6 is required for invadopodia activity and invasion by breast tumor cells
    Rey, Mercedes
    Irondelle, Marie
    Waharte, Francois
    Lizarraga, Floria
    Chavrier, Philippe
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2011, 90 (2-3) : 128 - 135
12345